These observations are consistent with the results obtained in the engineered CREBBPKO clones, providing support to the conclusion that KMT2D acetylation is impaired in CREBBP-mutant FL and DLBCL cases. The gene discussed is CREBBP; the disease is diffuse large B-cell lymphoma.